Popular on Rezul
- Tatanka Run Announces Phase-2 Development Following Completion of Phase-1 Spec Home - 140
- Hendricks Property Management #1 Property Manager in San Antonio & #27 Nationwide | Proudly Local
- Why Buying a Home at Christmas will be Your Best Christmas Ever
- Price Improvement on Luxurious Lāna'i Townhome with Stunning Ocean Views
- eJoule Inc Participates in Silicon Dragon CES 2026
- Central Florida Real Estate Market Shows Buyer-Friendly Shift Heading Into the New Year
- Tru by Hilton Columbia South Opens to Guests
- Beycome Closes $2.5M Seed Round Led by InsurTech Fund
- CredHub and Real Property Management Join Forces to Empower Franchise Owners with Rental Payment Credit Reporting Solutions
- Guests Can Save 25 Percent Off Last Minute Bookings at KeysCaribbean's Village at Hawks Cay Villas
Similar on Rezul
- Automation, innovation in healthcare processes featured at international conference in Atlanta
- High-Impact Mental Health Platform Approaching a Defining Regulatory Moment: Eclipsing 70,000 Patients on Real World Use of Ketamine: N ASDAQ: NRXP
- Report Outlines Key Questions for Individuals Exploring Anxiety Treatment Options in Toronto
- Rande Vick Introduces Radical Value, Challenging How Brands Measure Long-Term Value
- ASR Media, Social T Marketing & PR Announce Merger
- Former Google Search Team Member Launches AI-Powered SEO Consultancy in Las Vegas
- Acmeware and Avo Partner to Bring Real-Time Data Integration to MEDITECH Customers
- CCHR Says Mounting Evidence of Persistent Sexual Dysfunction From Antidepressants Demands FDA Action
- New Analysis Reveals Most Patients Discontinue Weight Loss Drugs Within First Year
- Preston Dermatology & Skin Surgery Center Wins Gold and Bronze in Prestigious Annual DIAMOND Awards
83bar publishes eight new reports from its Patient Activation market research
Rezul News/10437072
- Market research insights from recent patient activation tests using the 83bar integrated digital health platform
- Highlights from eight important medical categories, including depression, migraine, and NASH
- Implications of findings for pharma brands, medical devices, and clinical trial recruitment
- Highlights from eight important medical categories, including depression, migraine, and NASH
- Implications of findings for pharma brands, medical devices, and clinical trial recruitment
AUSTIN, Texas - Rezul -- 83bar, LLC has published a series of market research reports from its Patient Activation programs. The reports are now available with key findings and conclusions for eight important medical categories: cryotherapy, depression, melanoma, migraine, NASH, nerve pain, pediatric general anxiety disorder, and SUI.
83bar generated the data in the reports using its fully integrated digital health technology and clinical contact platform. The company already has achieved significant results with its process for provider networks, commercial clients, and clinical trial sponsors. These reports demonstrate the value of the approach in market research applications.
According to Bob Baurys, CEO of 83bar, "To make the most informed decisions, whether you're a healthcare provider or medical marketer, you need to know how the prospective patients will respond, which consumer segments will drive growth, and how messages might shift across categories. This series can guide your strategy with real-world, data-driven market research insights."
Alex Hilderbrand, vice president of patient activation & strategy at 83bar, directed the execution of the market research, as well as the compilation of the data analysis. He says, "Taken together, these reports offer a perspective on medical market trends and evolving healthcare consumer behaviors, supported by our proprietary system." Hilderbrand adds that studies reflected a total of more than 1,000 respondents across the eight markets.
More on Rezul News
Highlights from the 83bar Patient Activation market research reports:
More on Rezul News
For more information and to download any of these reports, visit our 83bar Market Research page.
The team at 83bar also offers custom research services providing focused, comprehensive, testing tailored to individual market needs and client strategies.
About 83bar, LLC
83bar, LLC, headquartered in Austin, Texas, is the leading patient activation marketing agency. 83bar has developed a system implemented by nearly three dozen name brands in health, medical, technology, and devices. The company has a database of more than 850,000 patient engagements over the past three years. Its four-step activation process is integrated to LOCATE prospective patients through risk assessment and health surveys; EDUCATE them to offer solutions and help them make informed decisions; NAVIGATE patients to action by appointment scheduling or service fulfillment; and through comprehensive follow-up, convert these patients to ADVOCATE on behalf of improved treatment and health care. Contact at www.go83bar.com
83bar generated the data in the reports using its fully integrated digital health technology and clinical contact platform. The company already has achieved significant results with its process for provider networks, commercial clients, and clinical trial sponsors. These reports demonstrate the value of the approach in market research applications.
According to Bob Baurys, CEO of 83bar, "To make the most informed decisions, whether you're a healthcare provider or medical marketer, you need to know how the prospective patients will respond, which consumer segments will drive growth, and how messages might shift across categories. This series can guide your strategy with real-world, data-driven market research insights."
Alex Hilderbrand, vice president of patient activation & strategy at 83bar, directed the execution of the market research, as well as the compilation of the data analysis. He says, "Taken together, these reports offer a perspective on medical market trends and evolving healthcare consumer behaviors, supported by our proprietary system." Hilderbrand adds that studies reflected a total of more than 1,000 respondents across the eight markets.
More on Rezul News
- $26 Billion Global Market by 2035 for Digital Assets Opens Major Potential for Currency Tech Company with ATM Expansion and Deployment Plans Underway
- Why OKC Homeowners Should Start the Year with Home Maintenance
- Peernovation 365 is Now Available
- SoilCertify - Professional Grade, 10M Resolution Soil Intelligence At A Fraction Of The Cost
- Living the Southern Utah Lifestyle, With Amy Hansen Real Estate
Highlights from the 83bar Patient Activation market research reports:
- Among Cryotherapy patients, there is significant interest in reducing pain reduction, improving athletic performance, and boosting metabolism. In addition, the report reveals an underlying concern with chronic depression or anxiety.
- The Depression study offers a profile of patients frustrated with current treatments. Almost all had difficulty attending work or school. Fully half have tried 4+ medications; yet 49% are not currently under care of psychiatrist. While majority were 18-50, one-third were 50+, revealing a significant opportunity with seniors.
- Melanoma patients who notice changes in skin appearance still may not connect to risk. Nearly 9 out of 10 were not diagnosed; specifically, one-third notice mole with uneven borders, but another one-third did not recognize signs. Half of respondents self-described as "analytical."
- The Migraine report shows more than 74% have been suffering for more than five years, and over 77% expressed dissatisfaction with their current treatment plan. Overwhelmingly, the majority of respondents are interested in migraine treatment options and clinical studies
- The NASH market test verified the ability of the 83bar method to attract hard-to-find patient prospects with pre-qualified medical conditions aligned to protocol inclusion and exclusion criteria for nonalcoholic steatohepatitis
- In the Nerve Pain survey, more than 6 out of 10 of those with deficit in chest and breast experience shooting pain in chest, armpit, or arm. Almost half have been experiencing symptoms more than 3 years, with significant impact on family and work quality of life.
- Results in Pediatric General Anxiety Disorder underscored children experiencing worries about school, friends, or activities, as well as lack of concentration and frequent stomach or headaches. It revealed that while 68% reported quality of life being "extremely" impacted, a significant 72% were not taking medication. Nearly a third of patients had been diagnosed by primary care or pediatricians other than a psychiatrist.
- In Stress Urinary Incontinence, the survey profiled patients frustrated with the impact on daily living. More than half are long-time sufferers; yet one-third have experienced symptoms only 1-3 years. It also showed a high incidence of lower back pain.
More on Rezul News
- How Florida real estate agents can protect their commissions
- Snap-a-Box Brings Texas' First Robot-Cooked Chinese Takeout to Katy–Fulshear
- UK Financial Ltd Makes History as MayaCat (SMCAT) Becomes the World's First Exchange-Traded ERC-3643 Security Token
- Manufacturing business owner and Tampa Bay economic development professional joins real estate firm
- Garden City Realty Recognizes December's Top Agents and Q4 Standout Performance
For more information and to download any of these reports, visit our 83bar Market Research page.
The team at 83bar also offers custom research services providing focused, comprehensive, testing tailored to individual market needs and client strategies.
About 83bar, LLC
83bar, LLC, headquartered in Austin, Texas, is the leading patient activation marketing agency. 83bar has developed a system implemented by nearly three dozen name brands in health, medical, technology, and devices. The company has a database of more than 850,000 patient engagements over the past three years. Its four-step activation process is integrated to LOCATE prospective patients through risk assessment and health surveys; EDUCATE them to offer solutions and help them make informed decisions; NAVIGATE patients to action by appointment scheduling or service fulfillment; and through comprehensive follow-up, convert these patients to ADVOCATE on behalf of improved treatment and health care. Contact at www.go83bar.com
Source: 83bar, LLC
0 Comments
Latest on Rezul News
- CES Spotlight Highlights Need for Strategic Review as Throughput Demands Evolve
- ASR Media, Social T Marketing & PR Announce Merger
- $780,000 Project for New Middle East Police Service with Deposit Received and Preliminary Design Work Underway for Lamperd: Stock Symbol: LLLI
- The 3rd Annual Newark Summit for Real Estate, Economic Development & Placemaking Returns February 9th
- Digital Security Deposit Platform Whale Raises $4 Million Seed Round Led by Camber Creek
- Ski Safety Awareness Month highlights why seeing clearly and wearing modern protection matters more than ever
- Vent Pros Expands Operations into Arizona to Meet Growing Demand for Commercial Ventilation and Kitchen Hood Cleaning Services
- Klein Civil Rights Expands with New Offices in New York's Historic Woolworth Building
- Biz Hub Financial Hosts 9th Annual Client Appreciation Event, Awards $1,000 CARES Community Grant
- Green Office Partner Appoints Aaron Smith as Chief Revenue and Growth Officer
- American Net Lease Facilitates Sale of McDonald's Ground Lease in Leander, Texas
- A Family Completes a Full Circumnavigation of the Globe in a Self-Contained Camper Van
- Andrew-Thomas Contractors Launches New Arvada Fence Installation Service Page
- Former Google Search Team Member Launches AI-Powered SEO Consultancy in Las Vegas
- Q3 2025 Arizona Technology Industry Impact Report Highlights Shifting Job Demand, Semiconductor Momentum and Workforce Investment
- $6.4 Million Purchase of Construction Vehicles Plus New Dealership Agreement with Cycle & Carriage for Heavy Equipment Provider to Singapore Region
- 2026 Vero Beach, FL Property Rental Forecast
- Acmeware and Avo Partner to Bring Real-Time Data Integration to MEDITECH Customers
- CCHR Says Mounting Evidence of Persistent Sexual Dysfunction From Antidepressants Demands FDA Action
- New Analysis Reveals Most Patients Discontinue Weight Loss Drugs Within First Year

